Pegvaliase – March 2026

Injection 2.5 mg in 0.5 mL pre-filled syringe, Injection 10 mg in 0.5 mL pre-filled syringe, Injection 20 mg in 1 mL pre-filled syringe

  • Brand names:
    • Palynziq®
  • Pharmaceutical Company:
    • BIOMARIN PHARMACEUTICAL AUSTRALIA PTY LTD
  • Condition/Indication: Phenylketonuria (PKU)
  • Meeting Date: March 2026
Public Summary Documents
Related Public Summary Documents
Last updated
11 March 2026